Eucrates Biomedical

$9.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.22 (-2.17%) As of 4:34 PM UTC today

Why Robinhood?

You can buy or sell EUCR and other stocks, options, and ETFs commission-free!

About EUCR

Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY. The listed name for EUCR is Eucrates Biomedical Acquisition Corp. Ordinary Shares.

CEO
Parag Saxena
Employees
—
Headquarters
New York, New York
Founded
—
Market Cap
136.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
34.54K
High Today
$10.12
Low Today
$9.87
Open Price
$10.12
Volume
5.33K
52 Week High
$10.88
52 Week Low
$9.76

You May Also Like

STCN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure